Pasadena, California
United States
70
2024-04-18
The entities that hold a legal rights for patent applications filed by inventor Baltimore David:
David Baltimore from Pasadena, US has applied for patents for these inventions. The list has both pending applications and granted patents:
LIGAND DISCOVERY FOR T CELL RECEPTORS
#2 | 2022-07-21Ligand discovery for T cell receptors
#3 | 2021-10-21COMPOSITION OF NY-ESO-1-SPECIFIC T CELL RECEPTORS RESTRICTED ON MULTIPLE MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES
#4 | 2020-12-24Ligand discovery for T cell receptors
#5 | 2020-12-24Ligand discovery for T cell receptors
#6 | 2020-10-01Trogocytosis mediated epitope discovery methods
#7 | 2019-10-17Packaging cell for making a pseudotyped lentivirus
#8 | 2019-07-04Signaling and antigen-presenting bifunctional receptors (SABR)
#9 | 2019-01-03Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#10 | 2018-08-16Method for expression of small RNA molecules within a cell
#11 | 2018-07-05MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders
#12 | 2018-06-28Methods of delivering a pseudotyped lentivirus
#13 | 2018-04-12Functional characterization of immune repertoires
#14 | 2017-07-06Ligand discovery for T cell receptors
#15 | 2017-04-27Use of chimeric nucleases to stimulate gene targeting
#16 | 2017-04-27Method for expression of small RNA molecules within a cell
#17 | 2017-04-20Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#18 | 2016-11-24Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#19 | 2016-08-25Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
#20 | 2016-08-04Method of targeting gene delivery using viral vectors
#21 | 2016-02-23Method for producing transgenic animals
#22 | 2015-08-06Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#23 | 2015-07-16Domain-swap T cell receptors
#24 | 2015-06-25Method of stimulating an immune response using a pseudotyped lentivirus
#25 | 2015-06-04Method for expression of small RNA molecules within a cell
#26 | 2015-01-08Delivery of proteins using adeno-associated virus (AAV) vectors
#27 | 2014-08-07MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders
#28 | 2014-07-31Targeting c-Rel O-GlcNAcylation and uses thereof
#29 | 2014-05-08Reversible gene expression
#30 | 2013-11-28Expression of secreted and cell-surface polypeptides
#31 | 2013-11-07Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#32 | 2013-10-03Method for expression of small RNA molecules within a cell
#33 | 2013-09-05Recombinant retrovirus pseudotyped with a E2 alphavirus glycoprotein
#34 | 2012-12-20Regulation of macrophage activation using miR-125b
#35 | 2012-09-13Delivery of proteins using adeno-associated virus (AAV) vectors
#36 | 2012-08-02MART-1 T cell receptors
#37 | 2012-05-17Use of SAM68 for modulating signaling through the TNF receptor
#38 | 2012-03-22Targeted gene delivery to dendritic cells
#39 | 2012-03-15Regulation of hematopoietic stem cell functions through microRNAs
#40 | 2012-03-15TREATMENT OF AUTOIMMUNE INFLAMMATION USING MIR-155
#41 | 2011-10-20MODULATING IMMUNE SYSTEM DEVELOPMENT AND FUNCTION THROUGH MICRORNA MIR-146
#42 | 2011-09-01Method of targeted gene delivery using viral vectors
#43 | 2011-04-05Method for expression of small antiviral RNA molecules within a cell
#44 | 2011-03-10Method for expression of small RNA molecules within a cell
#45 | 2011-01-20Isolation of unknown rearranged T-cell receptors from single cells
#46 | 2010-10-21Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#47 | 2010-08-12In vitro human B lymphopoiesis culture system
#48 | 2010-06-08Method for expression of small RNA molecules within a cell
#49 | 2010-05-13Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#50 | 2010-05-13Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#51 | 2009-08-13Modulating immune system development and function through microRNA MIR-146
#52 | 2008-12-04Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
#53 | 2008-08-21MART-1 T cell receptors
#54 | 2008-06-05Method for producing transgenic rats
#55 | 2008-01-29Method for producing transgenic birds and fish
#56 | 2008-01-24Targeted gene delivery for dendritic cell vaccination
#57 | 2008-01-03Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#58 | 2008-01-03Method for expression of small antiviral RNA molecules within a cell
#59 | 2007-10-04Modulation of innate immunity receptors' signaling by microRNAs miR-146a and miR-146b
#60 | 2007-05-24Method for the generation of antigen-specific lymphocytes
#61 | 2007-03-27Method for expression of small antiviral RNA molecules within a cell
#62 | 2007-01-25Method of targeted gene delivery using viral vectors
#63 | 2006-02-07Transcription factor regulators and methods for screening for same
#64 | 2005-12-08Chimeric pro-caspases and methods of using same
#65 | 2005-10-27Antigen specific T cell therapy
#66 | 2005-07-21Methods and compositions for inhibiting cell growth and proliferation
#67 | 2005-07-14Compositions for inducing cell growth and differentiation and methods of using same
#68 | 2005-07-12Chimeric pro-caspases and methods of using same
#69 | 2005-02-03Use of chimeric nucleases to stimulate gene targeting
#70 | 2005-01-13Method for the generation of antigen-specific lymphocytes
424182 ⎘